Review
BibTex RIS Cite

The Importance of Microbiota in Allergic Diseases

Year 2017, Volume: 9 Issue: 2, 69 - 73, 15.03.2017

Abstract

Abstract


Allergic diseases affect a significant part of the world population. The incidence of allergies in infancy is 10% but if there is an atopic background in the first generation relatives up to 20-30%. In recent years, the effects of intestinal flora have been debated in the onset of allergic diseases and in the increase of sensitization. The intestinal flora hypothesis has been proposed with the idea that flora may regulatethe immunological and inflammatory systemic response and the increased frequencyof allergic diseases. This review summarizes recent developments in the role of microbial in allergic diseases.

References

  • Kaynaklar 1.Cuello-Garcia CA, Brożek JL, Fiocchi A, Pawankar R, Yepes-Nuñez JJ, Terracciano L, Gandhi S, Agarwal A, Zhang Y,Schünemann HJ. Probiotics for the prevention of allergy: Asystematic review and meta-analysis of randomized control-led trials. J Allergy Clin Immunol. 2015. 2.Draaisma E, Garcia-Marcos L, Mallol J, Solé D, Pérez-Fer-nández V, Brand PL; EISL Study Group.. A multinational studyto compare prevalence of atopic dermatitis in the first year oflife. Pediatr Allergy Immunol. 2015 Jun;26(4):359-66. 3.Hoffjan S, Stemmler S. Unravelling the complex genetic backg-round of atopic dermatitis: from genetic association resultstowards novel therapeutic strategies. Arch Dermatol Res. 2015Oct;307(8):659-70. 4.Haahtela T, Holgate S, Pawankar R, Akdis CA, Benjaponpi-tak S, Caraballo L, Demain J, Portnoy J, von Hertzen L; WAOSpecial Committee on Climate Change and Biodiversity. Thebiodiversity hypothesis and allergic disease: world allergy or-ganization position statement. World Allergy Organ J. 2013. 5.Hanski I, von Hertzen L, Fyhrquist N, Koskinen K, Torppa K,Laatikainen T, Karisola P, Auvinen P, Paulin L, Mäkelä MJ,Vartiainen E, Kosunen TU, Alenius H, Haahtela T. Environmen-tal biodiversity, human microbiota, and allergy are interrela-ted. Proc Natl Acad Sci U S A. 2012 May 22;109(21):8334-9. 6.Shreiner A, Huffnagle GB, Noverr MC. The "MicrofloraHypothesis" of allergic disease. Adv Exp Med Biol.2008;635:113-34. 7.Björkstén B. Genetic and environmental risk factors for thedevelopment of food allergy Curr Opin Allergy Clin Immunol,5 (2005), pp. 249–253. 8.M. De Vrese, J. Schrezenmeir Probiotics, prebiotics, andsynbiotics Adv Biochem Eng Biotechnol, 111 (2008), pp. 1–66. 9.Matsuzaki T. Immunomodulation by treatment with Lactoba-cillus casei strain Shirota Int J Food Microbiol, 41 (1998 26),pp. 133–140. 10.Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesika-ri T. Improved immunogenicity of oral DxRRV reassortant ro-tavirus vaccine by Lactobacillus caseiGG Vaccine, 13 (1995),pp. 310–312 11.Fiocchi A, Burks W, Bahna SL, Bielory L, Boyle RJ, CoccoR et al. WAO Special Committee on Food Allergy and Nutri-tion. Clinical Use of Probiotics in Pediatric Allergy (CUPPA):A World Allergy Organization Position Paper. World AllergyOrgan J. 2012 Nov;5(11):148-67. 12.Winkler P, Ghadimi D, Schrezenmeir J, Kraehenbuhl J.P. Mo-lecular and cellular basis of microflora–host interactions JNutr, 137 (Suppl 2) (2007), pp. S756–S772. 13.Toh Z.Q , Anzela A, Tang M.L, Licciardi P.V. Probiotic the-rapy as a novel approach for allergic disease Front Pharma-col, 3 (2012), p. 171. 14.RL Bergmann, G Edenharter, KE Bergmann, J Forster, CPBauer, V Wahn, et al. Atopic dermatitis in early infancy pre-dicts allergic airway disease at 5 years Clin Exp Allergy, 28(1998), pp. 965–970. 15.Gourbeyre P, Denery S, Bodinier M. Probiotics, prebiotics,and synbiotics: impact on the gut immune system and aller-gic reactions J Leukoc Biol, 89 (2011), pp. 685–695. 16.Sepp E, Julge K, Vasar M, Naaber P, Bjorksten B, Mikelsa-ar M. Intestinal microflora of Estonian and Swedish infantsActa Paediatr, 86 (1997), pp. 956–961. 17.Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinalmicroflora in allergic Estonian and Swedish 2-year-oldchildren Clin Exp Allergy, 29 (1999), pp. 342–346. 18.Munoz F-Lopez Mucosal allergy and probiotics Allergol Im-munopathol, 32 (2004), pp. 313–315. 19.Hijazi Z, Molla AM, Al-Habashi H, Muawad WM, Sharma PN.Intestinal permeability is increased in bronchial asthmaArch Dis Child, 89 (2004), pp. 227–229. 20.Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Pro-biotics in the management of atopic eczema Clin Exp Allergy,30 (2000), pp. 1604–1610. 21.Majamaa H, Isolauri E. Probiotics: a novel approach in themanagement of food allergy J Allergy Clin Immunol, 99 (1997),pp. 179–185. 22.MF Wang, HC Lin, YY Wang, CH Hsu. Treatment of peren-nial allergic rhinitis with lactic acid bacteria Pediatr AllergyImmunol, 15 (2004), pp. 152–158. 23.G Ciprandi, A Vizzaccaro, I Cirillo, A Tosca. Bacillus clau-sii effects in children with allergic rhinitis Allergy, 60 (2005),pp. 702–703. 24.R Lodinova-Zadnikova, B Cukrowska, H Tlaskalova-Hageno-va. Oral adminstration of probiotic Escherichia coli after birthreduces frequency of allergies and repeated infections laterin life (after 10 and 20 years) Int Arch Allergy Immunol, 131(2003), pp. 209–211. 25.Pv Kirjavainen, T Arvola, Sj Salminen, E Isolauri. Aberrantcomposition of gut microbiota of allergic infants: a target ofbifidobacterial therapy at weaning? Gut, 51 (2002), pp. 51–55. 26.Del Giudice MM, Rocco A, Capristo C. Probiotics in the ato-pic march: highlights and new insights. Dig Liver Dis. 2006Dec;38 Suppl 2:S288-90. 27.Abrahamsson TR, Jakobsson T, Björkstén B, Oldaeus G, Jen-malm MC. No effect of probiotics on respiratory allergies: aseven-year follow-up of a randomized controlled trial in in-fancy. Pediatr Allergy Immunol. 2013 Sep;24(6):556-61. 28.Tang RB, Chang JK, Chen HL. Can probiotics be used to treatallergic diseases? J Chin Med Assoc. 2015 Mar;78(3):154-7. 29.Foisy M, Boyle RJ, Chalmers JR, Simpson EL, Williams HC.Overview of Reviews The prevention of eczema in infants andchildren: an overview of Cochrane and non-Cochrane revi-ews. Evid Based Child Health. 2011 Sep;6(5):1322-1339.

Alerjik Hastalıklarda Mikrobiyotanın Önemi

Year 2017, Volume: 9 Issue: 2, 69 - 73, 15.03.2017

Abstract

Öz

Alerjik hastalıklar dünya nüfusunun önemli bir kısmını etkilemektedir. Süt çocuklarında alerji sıklığı %10 birinci kuşak akrabalarında atopik zemin varsa %20-30’akadar yükselmektedir. Son yıllarda alerjik hastalıkların başlangıcı ve duyarlanmanın artmasında bağırsak florasının etkileri tartışılmaktadır. Flora immünolojik ve inflamatuvar sistemik yanıtı düzenliyor olabileceği fikri ile alerjik hastalıkların sıklığının artışı ile intestinal flora hipotezi ileri sürülmüştür. Bu derlemede alerjik hastalıklarda mikrobiyotanın rolü ile ilgili son gelişmeler özetlenmiştir.

References

  • Kaynaklar 1.Cuello-Garcia CA, Brożek JL, Fiocchi A, Pawankar R, Yepes-Nuñez JJ, Terracciano L, Gandhi S, Agarwal A, Zhang Y,Schünemann HJ. Probiotics for the prevention of allergy: Asystematic review and meta-analysis of randomized control-led trials. J Allergy Clin Immunol. 2015. 2.Draaisma E, Garcia-Marcos L, Mallol J, Solé D, Pérez-Fer-nández V, Brand PL; EISL Study Group.. A multinational studyto compare prevalence of atopic dermatitis in the first year oflife. Pediatr Allergy Immunol. 2015 Jun;26(4):359-66. 3.Hoffjan S, Stemmler S. Unravelling the complex genetic backg-round of atopic dermatitis: from genetic association resultstowards novel therapeutic strategies. Arch Dermatol Res. 2015Oct;307(8):659-70. 4.Haahtela T, Holgate S, Pawankar R, Akdis CA, Benjaponpi-tak S, Caraballo L, Demain J, Portnoy J, von Hertzen L; WAOSpecial Committee on Climate Change and Biodiversity. Thebiodiversity hypothesis and allergic disease: world allergy or-ganization position statement. World Allergy Organ J. 2013. 5.Hanski I, von Hertzen L, Fyhrquist N, Koskinen K, Torppa K,Laatikainen T, Karisola P, Auvinen P, Paulin L, Mäkelä MJ,Vartiainen E, Kosunen TU, Alenius H, Haahtela T. Environmen-tal biodiversity, human microbiota, and allergy are interrela-ted. Proc Natl Acad Sci U S A. 2012 May 22;109(21):8334-9. 6.Shreiner A, Huffnagle GB, Noverr MC. The "MicrofloraHypothesis" of allergic disease. Adv Exp Med Biol.2008;635:113-34. 7.Björkstén B. Genetic and environmental risk factors for thedevelopment of food allergy Curr Opin Allergy Clin Immunol,5 (2005), pp. 249–253. 8.M. De Vrese, J. Schrezenmeir Probiotics, prebiotics, andsynbiotics Adv Biochem Eng Biotechnol, 111 (2008), pp. 1–66. 9.Matsuzaki T. Immunomodulation by treatment with Lactoba-cillus casei strain Shirota Int J Food Microbiol, 41 (1998 26),pp. 133–140. 10.Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesika-ri T. Improved immunogenicity of oral DxRRV reassortant ro-tavirus vaccine by Lactobacillus caseiGG Vaccine, 13 (1995),pp. 310–312 11.Fiocchi A, Burks W, Bahna SL, Bielory L, Boyle RJ, CoccoR et al. WAO Special Committee on Food Allergy and Nutri-tion. Clinical Use of Probiotics in Pediatric Allergy (CUPPA):A World Allergy Organization Position Paper. World AllergyOrgan J. 2012 Nov;5(11):148-67. 12.Winkler P, Ghadimi D, Schrezenmeir J, Kraehenbuhl J.P. Mo-lecular and cellular basis of microflora–host interactions JNutr, 137 (Suppl 2) (2007), pp. S756–S772. 13.Toh Z.Q , Anzela A, Tang M.L, Licciardi P.V. Probiotic the-rapy as a novel approach for allergic disease Front Pharma-col, 3 (2012), p. 171. 14.RL Bergmann, G Edenharter, KE Bergmann, J Forster, CPBauer, V Wahn, et al. Atopic dermatitis in early infancy pre-dicts allergic airway disease at 5 years Clin Exp Allergy, 28(1998), pp. 965–970. 15.Gourbeyre P, Denery S, Bodinier M. Probiotics, prebiotics,and synbiotics: impact on the gut immune system and aller-gic reactions J Leukoc Biol, 89 (2011), pp. 685–695. 16.Sepp E, Julge K, Vasar M, Naaber P, Bjorksten B, Mikelsa-ar M. Intestinal microflora of Estonian and Swedish infantsActa Paediatr, 86 (1997), pp. 956–961. 17.Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinalmicroflora in allergic Estonian and Swedish 2-year-oldchildren Clin Exp Allergy, 29 (1999), pp. 342–346. 18.Munoz F-Lopez Mucosal allergy and probiotics Allergol Im-munopathol, 32 (2004), pp. 313–315. 19.Hijazi Z, Molla AM, Al-Habashi H, Muawad WM, Sharma PN.Intestinal permeability is increased in bronchial asthmaArch Dis Child, 89 (2004), pp. 227–229. 20.Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Pro-biotics in the management of atopic eczema Clin Exp Allergy,30 (2000), pp. 1604–1610. 21.Majamaa H, Isolauri E. Probiotics: a novel approach in themanagement of food allergy J Allergy Clin Immunol, 99 (1997),pp. 179–185. 22.MF Wang, HC Lin, YY Wang, CH Hsu. Treatment of peren-nial allergic rhinitis with lactic acid bacteria Pediatr AllergyImmunol, 15 (2004), pp. 152–158. 23.G Ciprandi, A Vizzaccaro, I Cirillo, A Tosca. Bacillus clau-sii effects in children with allergic rhinitis Allergy, 60 (2005),pp. 702–703. 24.R Lodinova-Zadnikova, B Cukrowska, H Tlaskalova-Hageno-va. Oral adminstration of probiotic Escherichia coli after birthreduces frequency of allergies and repeated infections laterin life (after 10 and 20 years) Int Arch Allergy Immunol, 131(2003), pp. 209–211. 25.Pv Kirjavainen, T Arvola, Sj Salminen, E Isolauri. Aberrantcomposition of gut microbiota of allergic infants: a target ofbifidobacterial therapy at weaning? Gut, 51 (2002), pp. 51–55. 26.Del Giudice MM, Rocco A, Capristo C. Probiotics in the ato-pic march: highlights and new insights. Dig Liver Dis. 2006Dec;38 Suppl 2:S288-90. 27.Abrahamsson TR, Jakobsson T, Björkstén B, Oldaeus G, Jen-malm MC. No effect of probiotics on respiratory allergies: aseven-year follow-up of a randomized controlled trial in in-fancy. Pediatr Allergy Immunol. 2013 Sep;24(6):556-61. 28.Tang RB, Chang JK, Chen HL. Can probiotics be used to treatallergic diseases? J Chin Med Assoc. 2015 Mar;78(3):154-7. 29.Foisy M, Boyle RJ, Chalmers JR, Simpson EL, Williams HC.Overview of Reviews The prevention of eczema in infants andchildren: an overview of Cochrane and non-Cochrane revi-ews. Evid Based Child Health. 2011 Sep;6(5):1322-1339.
There are 1 citations in total.

Details

Primary Language Turkish
Journal Section makale
Authors

Prof. Dr. Özkan Karaman This is me

Publication Date March 15, 2017
Published in Issue Year 2017 Volume: 9 Issue: 2

Cite

APA Karaman, P. D. Ö. (2017). Alerjik Hastalıklarda Mikrobiyotanın Önemi. Klinik Tıp Pediatri Dergisi, 9(2), 69-73.
AMA Karaman PDÖ. Alerjik Hastalıklarda Mikrobiyotanın Önemi. Pediatri. March 2017;9(2):69-73.
Chicago Karaman, Prof. Dr. Özkan. “Alerjik Hastalıklarda Mikrobiyotanın Önemi”. Klinik Tıp Pediatri Dergisi 9, no. 2 (March 2017): 69-73.
EndNote Karaman PDÖ (March 1, 2017) Alerjik Hastalıklarda Mikrobiyotanın Önemi. Klinik Tıp Pediatri Dergisi 9 2 69–73.
IEEE P. D. Ö. Karaman, “Alerjik Hastalıklarda Mikrobiyotanın Önemi”, Pediatri, vol. 9, no. 2, pp. 69–73, 2017.
ISNAD Karaman, Prof. Dr. Özkan. “Alerjik Hastalıklarda Mikrobiyotanın Önemi”. Klinik Tıp Pediatri Dergisi 9/2 (March 2017), 69-73.
JAMA Karaman PDÖ. Alerjik Hastalıklarda Mikrobiyotanın Önemi. Pediatri. 2017;9:69–73.
MLA Karaman, Prof. Dr. Özkan. “Alerjik Hastalıklarda Mikrobiyotanın Önemi”. Klinik Tıp Pediatri Dergisi, vol. 9, no. 2, 2017, pp. 69-73.
Vancouver Karaman PDÖ. Alerjik Hastalıklarda Mikrobiyotanın Önemi. Pediatri. 2017;9(2):69-73.